BioAtla (BCAB) FCF Margin (2020 - 2025)

BioAtla's FCF Margin history runs 4 years deep, the most recent figure standing at 395.75% for Q4 2025.

• On a quarterly basis, FCF Margin changed N/A year-over-year to 395.75% in Q4 2025; TTM through Dec 2025 was 370.8%, a 28316.0% increase from a year earlier, with the FY2025 full-year figure at 2410.2%, down 175624.0% from the prior year.
• FCF Margin declined to 395.75% in Q4 2025 per BCAB's latest filing, from 46.65% in the prior quarter.
• Across five years, FCF Margin topped out at 46.65% in Q3 2024 and bottomed at 5234.4% in Q2 2021.
• The 3-year median for FCF Margin is 395.75% (2025), against an average of 1892.27%.
• Biggest YoY gain for FCF Margin was 366440 bps in 2021; the steepest drop was 366440 bps in 2021.
• Year by year, FCF Margin stood at 5234.4% in 2021, then surged by 99 bps to 46.65% in 2024, then tumbled by 748 bps to 395.75% in 2025.
• Per Business Quant, the three latest BCAB FCF Margin figures stand at 395.75% (Q4 2025), 46.65% (Q3 2024), and 5234.4% (Q2 2021).